Table 4.
Stool consistency profile over the intervention period.
| Subjects (n, %) | ||||
|---|---|---|---|---|
| Group | Stool type (BSS) | Day 0 | Day 21 | Day 42 |
| Placebo (n = 109) |
Constipation (1–2) | 25 (22.9) | 19 (17.4) | 28 (25.7) |
| Normal (3–5) | 70 (64.2) | 74 (67.9) | 68 (62.4) | |
| Diarrhea (6–7) | 14 (12.8) | 14 (12.8) | 11 (10.1) | |
| Data not available | 0 | 2 (1.8) | 2 (1.8) | |
|
L. acidophilus DDS-1 (n = 111) |
Constipation (1–2) | 24 (21.6) | 14 (12.6) | 9 (8.1) |
| Normal (3–5) | 63 (56.8) | 82 (73.9) | 93 (83.8) | |
| Diarrhea (6–7) | 24 (21.6) | 13 (11.7) | 7 (6.3) | |
| Data not available | 0 | 2 (1.8) | 2 (1.8) | |
|
B. lactis UABla-12 (n = 110) |
Constipation (1–2) | 22 (20.0) | 18 (16.4) | 10 (9.1) |
| Normal (3–5) | 67 (60.9) | 63 (57.3) | 83 (75.5) | |
| Diarrhea (6–7) | 21 (19.1) | 24 (21.8) | 12 (10.9) | |
| Data not available | 0 | 5 (4.5) | 5 (4.5) | |
| p Value † | DDS-1 vs. Placebo | 0.234 | 0.733 | 0.002 |
| UABla-12 vs. Placebo | 0.438 | 0.444 | 0.022 | |
| DDS-1 vs. UABla-12 | 0.139 | 0.234 | 0.435 | |
† Between group comparison, Pearson Chi Square test. BSS: Bristol Stool Scale.